Eczema News and Research

Latest Eczema News and Research

Levels of urinary eosinophil protein-X may predict future atopy in asymptomatic children

The signs of atopy may be present long before symptoms begin, even in month-old babies, according to a new research study from Denmark. The study found that the level of urinary eosinophil protein-X (u-EPX), a marker of inflammatory cells, in newborn babies was linked to higher risk of allergic sensitization, nasal eosinophilia and eczema at six years.

7 Jul 2011

Air traffic pollution impacts growth and development of unborn children

A UK academic is calling for a nationwide study into the effects traffic pollution has on asthma sufferers after his own research in Cairo highlighted health problems in children who may even be affected while still in the womb.

6 Jul 2011

Moberg Derma receives EU/EEA CE mark approval for Kaprolac Skin Repair & Hydration

Moberg Derma AB announced that CE mark has been granted for Kaprolac Skin Repair & Hydration, a product designed to treat atopic eczema and dry skin. This CE mark provides authorization to market and sell the product in the EU/EEA.

10 Jun 2011

Moisturisers, hair dyes cause serious adverse effects

Permanent hair dye gives the most serious adverse effects, yet there are also many reactions to facial and body moisturisers. This comes from the first report from the National Register of Adverse Effects from Cosmetic Products published by the Norwegian Institute of Public Health.

31 May 2011

Invida announces launch of novel atopic dermatitis symptomatic treatment

Invida Group Private Limited reaffirmed its commitment to patients in Asia Pacific by announcing the launch of a novel atopic dermatitis symptomatic treatment, Atopiclair, which will be available to patients across Asia in second half of 2011.

26 May 2011

Study: Healthy gut flora reduces risk of obesity and body's low-level inflammation

Poor gut flora is believed to trigger obesity. In the same way, healthy gut flora could reduce the risk. This has shown to be the case in tests on rats.

26 May 2011

Breastfeeding leads to better behaviour in kids: Study

A new study shows that just four months of breastfeeding can cut the risk of children becoming badly behaved by almost a third. It found 16 per cent of children brought up on formula milk had problems including anxiety, lying, stealing and hyperactivity – more than double the proportion breastfed for at least four months.

10 May 2011

New insight into itch and pain

A new study of itch adds to growing evidence that the chemical signals that make us want to scratch are the same signals that make us wince in pain.

3 May 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

ProtoKinetix, Imaginative Research Associates partner to formulate topical anti-inflammation product

ProtoKinetix, is pleased to announce, that it has entered into a Joint Venture Agreement with Imaginative Research Associates, Inc. to formulate a topical anti-inflammation product for the skin care market.

27 Apr 2011

Corticosteroid creams do not cause skin thinning: Study

According to a new study, long term use of steroid creams to treat children with the skin condition known as eczema doesn't cause any major negative side effects.

25 Apr 2011

Psoriasis patients still need long-established treatment alternatives

For patients with severe psoriasis, a new class of intravenous and injectable biological medicines known as "biologics" has brought about a near revolution in treatment.

21 Apr 2011

Normal routine use of topical corticosteroids for eczema in children does not 'thin the skin'

A new study published in the journal Pediatric Dermatology reveals that routine, long-term use of topical corticosteroids (TCS) for treating children with eczema does not cause any significant, negative side effects.

21 Apr 2011

Children who have eczema with hay fever more likely to develop allergic asthma

Children who have eczema, particularly when occurring with hay fever, are nine times more likely to develop allergic asthma in their 40s, a new study reveals.

16 Apr 2011

New treatment improves immune function in 13-year-old with Wiskott-Aldrich syndrome

In a novel approach that works around the gene defect in Wiskott-Aldrich syndrome, an inherited immune deficiency disorder, researchers used an alternative cell signaling pathway to significantly improve immune function in a 13-year-old boy with the disease.

15 Apr 2011

Vertex announces final results from Phase 3 REALIZE study against HCV

Vertex Pharmaceuticals Incorporated today announced final results from its pivotal Phase 3 REALIZE study that evaluated people with genotype 1 chronic hepatitis C whose prior treatment with pegylated-interferon and ribavirin was unsuccessful either because they relapsed, had a partial response or had a null response.

1 Apr 2011

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Amgen today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis.

24 Mar 2011

Insight into 'contagious itch'

Can you catch an itch? The answer is yes. Dermatologist Gil Yosipovitch, M.D., of Wake Forest Baptist Medical Center, has been researching what's known as "contagious itch."

23 Mar 2011

Insight into photodermatoses

One in ten people react to sunlight by developing eczema. This abnormal reaction is one of a group of disorders known as photodermatoses.

17 Mar 2011

Peanut allergy has a genetic link: Study

A new study suggests that children with a certain gene defect are more likely to develop a peanut allergy. They studied the effect of changes in the gene filaggrin, which helps the skin block out allergens. They noted what has been seen before – the changes in the gene reduce the effectiveness of the barrier, increasing the risk for eczema and asthma.

14 Mar 2011

Eczema News and Research

Latest Eczema News and Research

Levels of urinary eosinophil protein-X may predict future atopy in asymptomatic children

Air traffic pollution impacts growth and development of unborn children

Moberg Derma receives EU/EEA CE mark approval for Kaprolac Skin Repair & Hydration

Moisturisers, hair dyes cause serious adverse effects

Invida announces launch of novel atopic dermatitis symptomatic treatment

Study: Healthy gut flora reduces risk of obesity and body's low-level inflammation

Breastfeeding leads to better behaviour in kids: Study

New insight into itch and pain

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

ProtoKinetix, Imaginative Research Associates partner to formulate topical anti-inflammation product

Corticosteroid creams do not cause skin thinning: Study

Psoriasis patients still need long-established treatment alternatives

Normal routine use of topical corticosteroids for eczema in children does not 'thin the skin'

Children who have eczema with hay fever more likely to develop allergic asthma

New treatment improves immune function in 13-year-old with Wiskott-Aldrich syndrome

Vertex announces final results from Phase 3 REALIZE study against HCV

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Insight into 'contagious itch'

Insight into photodermatoses

Peanut allergy has a genetic link: Study

Innovation in neuroscience drug discovery - eBook eBook

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Eczema News and Research

Latest Eczema News and Research

Innovation in neuroscience drug discovery - eBook eBook

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

The evolution of OCT for retinal imaging and disease intervention

Newsletters you may be interested in